Trimethoprim-sulfamethoxazole exposure alters exvivo functionofblymphocytes isolated from human immunodeficiency virus-infected patients receiving zidovudine

Pharmacotherapy

Volumn 29, Issue 4, 2009, Pages 373-382

  Venugopalan, Veena ^a   Thornton, Alice C ^a   Steinke, Douglass T ^a   Rapp, Robert P ^a   Romanelli, Frank ^a   Feola, David J ^a,b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b University of Kentucky   (United States)

Author keywords

Adverse drug reactions; HIV; Human immunodeficiency virus; Immunology; TMP SMX; Trimethoprimsulfamethoxazole; Zidovudine

Indexed keywords

COTRIMOXAZOLE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; PHYTOHEMAGGLUTININ; POKEWEED MITOGEN; TUMOR NECROSIS FACTOR ALPHA; ZIDOVUDINE;

ADULT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE ACTIVATION; CD4 LYMPHOCYTE COUNT; CELL ISOLATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYTOKINE RELEASE; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MALE; OUTPATIENT DEPARTMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PROSPECTIVE STUDY; T LYMPHOCYTE ACTIVATION; TREATMENT DURATION; UNIVERSITY HOSPITAL; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; ANTI-INFECTIVE AGENTS; B-LYMPHOCYTES; CROSS-OVER STUDIES; CYTOKINES; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; ZIDOVUDINE;

EID: 64849102423     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.29.4.373     Document Type: Article

References (43)

1. Martinez-Maza O, Crabb E, Mitsuyasu RT, Fahey JL, Giorgi JV. Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J Immunol 1987;138:3720-4.
2. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983;309:453-8.
3. Ammann AJ, Schiffman G, Abrams D, Volberding P, Ziegler J, Conant M. B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA 1984;251:1447-9.
4. Simberkoff MS, El Sadr W, Schiffman G, Rahal JJ Jr. Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure. Am Rev Respir Dis 1984; 130:1174-6.
5. Bernstein LJ, Ochs HD, Wedgwood RJ, Rubinstein A. Defective humoral immunity in pediatric acquired immune deficiency syndrome. J Pediatr 1985;107:352-7.
6. Ballet JJ, Sulcebe G, Couderc LJ, et al. Impaired antipneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy. Clin Exp Immunol 1987;68:479-87.
7. Janoff EN, Douglas JM Jr, Gabriel M, et al. Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1. J Infect Dis 1988;158:983-90.
8. De Milito A, Nilsson A, Titanji K, et al. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 2004;103:2180-6.
9. Kovacs JA, Hiemenz JW, Macher AM, et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984;100:663-71.
10. + T helper cell depletion occurs. J Clin Invest 1988;82:1908-14.
11. Terpstra FG, Al BJ, Roos MT, et al. Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: rapid and persistent loss of B cell function after HIV infection. Eur J Immunol 1989;19:667-73.
12. Schnittman SM, Lane HC, Higgins SE, Folks T, Fauci AS. Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. Science 1986;233:1084-6.
13. Macchia D, Almerigogna F, Parronchi P, Ravina A, Maggi E, Romagnani S. Membrane tumour necrosis factor-α is involved in the polyclonal B-cell activation induced by HIV-infected human T cells. Nature 1993;363:464-6.
14. Amadori A, Zamarchi R, Veronese ML, et al. B cell activation during HIV-1 infection. II. Cell-to-cell interactions and cytokine requirement. J Immunol 1991;146:57-62.
15. Muller F, Aukrust P, Nordoy I, Froland SS. Possible role of interleukin-10 (IL-10) and CD40 ligand expression in the pathogenesis of hypergammaglobulinemia in human immunodeficiency virus infection: modulation of IL-10 and Ig production after intravenous Ig infusion. Blood 1998;92: 3721-9.
16. Heffernan RT, Barrett NL, Gallagher KM, et al. Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. J Infect Dis 2005;191:2038-45.
17. De Milito A, Morch C, Sonnerborg A, Chiodi F. Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS 2001;15:957-64.
18. Nagase H, Agematsu K, Kitano K, et al. Mechanism of hypergammaglobulinemia by HIV infection: circulating memory B-cell reduction with plasmacytosis. Clin Immunol 2001;100:250-9.
19. Morris L, Binley JM, Clas BA, et al. HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med 1998;188:233-45.
20. Notermans DW, de Jong JJ, Goudsmit J, et al. Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses. AIDS Res Hum Retroviruses 2001;17: 1003-8.
21. Titanji K, De Milito A, Cagigi A, et al. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 2006;108:1580-7.
22. Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents, January 29, 2008. Available from http://www.aidsinfo.nih.gov/ContentFiles/ AdultandAdolescentGL.pdf. Accessed September 5, 2008.
23. Kaplan JE, Masur H, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons-2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 2002;51:1-52.
24. Tseng A, Conly J, Fletcher D, Keystone D, Salit I, Walmsley S. Precipitous declines in hemoglobin levels associated with combination zidovudine and lamivudine therapy. Clin Infect Dis 1998;27:908-9.
25. Richman DD, Fischl MA, Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987;317:192-7.
26. McKinney RE Jr, Maha MA, Connor EM, et al, for the Protocol 043 Study Group. A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. N Engl J Med 1991;324:1018-25.
27. Gill PS, Rarick M, Brynes RK, Causey D, Loureiro C, Levine AM. Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1987;107:502-5.
28. Furman PA, Fyfe JA, St Clair MH, et al. Phosphorylation of 3'- azido-3'-deoxythymidine and selective interaction of the 5'- triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A 1986;83:8333-7.
29. Dainiak N, Worthington M, Riordan MA, Kreczko S, Goldman L. 3'-Azido-3'-deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells. Br J Haematol 1988;69:299-304.
30. Bogliolo G, Lerza R, Mencoboni M, Saviane A, Pannacciulli I. Azidothymidine-induced depression of murine hemopoietic progenitor cells. Exp Hematol 1988;16:938-40.
31. Gordin FM, Simon GL, Wofsy CB, Mills J. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1984;100: 495-9.
32. Carr A, Tindall B, Penny R, Cooper DA. Patterns of multipledrug hypersensitivities in HIV-infected patients. AIDS 1993;7:1532-3.
33. Buhl R, Jaffe HA, Holroyd KJ, et al. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 1989;2:1294-8.
34. Carr A, Tindall B, Penny R, Cooper DA. In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV. Clin Exp Immunol 1993;94:21-5.
35. Freund YR, Dousman L, MacGregor JT, Mohagheghpour N. Oral treatment with trimethoprim-sulfamethoxazole and zidovudine suppresses murine accessory cell-dependent immune responses. Toxicol Sci 2000;55:335-42.
36. Feola DJ, Garvy BA. Combination exposure to zidovudine plus sulfamethoxazole-trimethoprim diminishes B-lymphocyte immune responses to Pneumocystis murina infection in healthy mice. Clin Vaccine Immunol 2006;13:193-201.
37. Feola DJ, Garvy BA, Rapp RP, Thornton AC. Blunted humoral response to influenza vaccination in patients exposed to zidovudine plus trimethoprim-sulfamethoxazole. Pharmacotherapy 2007;27:937-47.
38. Feola DJ, Garvy BA. Zidovudine plus sulfamethoxazoletrimethoprim adversely affects B lymphocyte maturation in bone marrow of normal mice. Int Immunopharmacol 2005;5:1881-94.
39. Ugrinovic S, Menager N, Goh N, Mastroeni P. Characterization and development of T-cell immune responses in B- cell-deficient (Igh-6(-/-)) mice with Salmonella enterica serovar Typhimurium infection. Infect Immun 2003;71:6808-19.
40. Linton PJ, Harbertson J, Bradley LM. A critical role for B cells in the development of memory CD4 cells. J Immunol 2000;165:5558-65.
41. Lund FE, Schuer K, Hollifield M, Randall TD, Garvy BA. Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P. carinii-specific antibody. J Immunol 2003;171:1423-30.
42. Lane P, Traunecker A, Hubele S, Inui S, Lanzavecchia A, Gray D. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T celldependent activation of B lymphocytes. Eur J Immunol 1992;22:2573-8.
43. Snapper CM, Kehry MR, Castle BE, Mond JJ. Multivalent, but not divalent, antigen receptor cross-linkers synergize with CD40 ligand for induction of Ig synthesis and class switching in normal murine B cells: a redefinition of the TI-2 vs T celldependent antigen dichotomy. J Immunol 1995;154:1177-87.